These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32439401)

  • 1. Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders.
    Walter HJ; Bukstein OG; Abright AR; Keable H; Ramtekkar U; Ripperger-Suhler J; Rockhill C
    J Am Acad Child Adolesc Psychiatry; 2020 Oct; 59(10):1107-1124. PubMed ID: 32439401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis.
    Stefánsdóttir ÍH; Ivarsson T; Skarphedinsson G
    Nord J Psychiatry; 2023 Feb; 77(2):137-146. PubMed ID: 35587815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Major and Persistent Depressive Disorders.
    Walter HJ; Abright AR; Bukstein OG; Diamond J; Keable H; Ripperger-Suhler J; Rockhill C
    J Am Acad Child Adolesc Psychiatry; 2023 May; 62(5):479-502. PubMed ID: 36273673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Pharmacotherapy for Pediatric Anxiety Disorders.
    Nicotra CM; Strawn JR
    Child Adolesc Psychiatr Clin N Am; 2023 Jul; 32(3):573-587. PubMed ID: 37201968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Development on Antidepressant and Placebo Response in Anxiety Disorders: A Bayesian Hierarchical Meta-Analytic Examination of Randomized Controlled Trials in Children, Adolescents, and Adults.
    Mills JA; Mendez E; Strawn JR
    J Child Adolesc Psychopharmacol; 2024 Sep; 34(7):302-309. PubMed ID: 38800869
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebrovascular, Cardiovascular, and Mortality Events in New Users of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: A Propensity Score-Matched Population-Based Study.
    Leong C; Alessi-Severini S; Enns MW; Nie Y; Sareen J; Bolton J; Prior HJ; Chateau D
    J Clin Psychopharmacol; 2017 Jun; 37(3):332-340. PubMed ID: 28383363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
    Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
    Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of cognitive behavioral treatment, serotonin, and serotonin noradrenaline reuptake inhibitors for anxiety in children and adolescents: a network meta-analysis.
    Arnardóttir A; Skarphedinsson G
    Nord J Psychiatry; 2023 Feb; 77(2):118-126. PubMed ID: 35507829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.
    Strawn JR; Mills JA; Sauley BA; Welge JA
    J Am Acad Child Adolesc Psychiatry; 2018 Apr; 57(4):235-244.e2. PubMed ID: 29588049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining selective serotonin reuptake inhibitors and cognitive behavioral therapy in youth with depression and anxiety.
    Strawn JR; Mills JA; Suresh V; Peris TS; Walkup JT; Croarkin PE
    J Affect Disord; 2022 Feb; 298(Pt A):292-300. PubMed ID: 34728290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents.
    Strawn JR; Mills JA; Poweleit EA; Ramsey LB; Croarkin PE
    Pharmacotherapy; 2023 Jul; 43(7):675-690. PubMed ID: 36651686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis.
    Wang Z; Whiteside SPH; Sim L; Farah W; Morrow AS; Alsawas M; Barrionuevo P; Tello M; Asi N; Beuschel B; Daraz L; Almasri J; Zaiem F; Larrea-Mantilla L; Ponce OJ; LeBlanc A; Prokop LJ; Murad MH
    JAMA Pediatr; 2017 Nov; 171(11):1049-1056. PubMed ID: 28859190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.
    Locher C; Koechlin H; Zion SR; Werner C; Pine DS; Kirsch I; Kessler RC; Kossowsky J
    JAMA Psychiatry; 2017 Oct; 74(10):1011-1020. PubMed ID: 28854296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacologic treatment of children and adolescents with anxiety disorders.
    Strawn JR; Sakolsky DJ; Rynn MA
    Child Adolesc Psychiatr Clin N Am; 2012 Jul; 21(3):527-39. PubMed ID: 22800992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder.
    Castagna PJ; Farahdel E; Potenza MN; Crowley MJ
    Expert Opin Pharmacother; 2023 May; 24(7):835-847. PubMed ID: 37074259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: a longitudinal and prospective study.
    Benítez CI; Smith K; Vasile RG; Rende R; Edelen MO; Keller MB
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):5-13. PubMed ID: 18165458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Treatment for Pediatric Anxiety Disorders.
    Wesemann D
    J Psychosoc Nurs Ment Health Serv; 2022 Sep; 60(9):6-9. PubMed ID: 36044745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.
    Buszewicz M; Cape J; Serfaty M; Shafran R; Kabir T; Tyrer P; Clarke CS; Nazareth I
    Health Technol Assess; 2017 Aug; 21(45):1-138. PubMed ID: 28853392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of anxiety, obsessive-compulsive, and stress disorders: a systematic review and network meta-analysis.
    Gosmann NP; Costa MA; Jaeger MB; Frozi J; Spanemberg L; Manfro GG; Cortese S; Cuijpers P; Pine DS; Salum GA
    Psychol Med; 2023 Jul; 53(9):3783-3792. PubMed ID: 37278215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.